These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10465113)

  • 41. Functional analysis of diastrophic dysplasia sulfate transporter. Its involvement in growth regulation of chondrocytes mediated by sulfated proteoglycans.
    Satoh H; Susaki M; Shukunami C; Iyama K; Negoro T; Hiraki Y
    J Biol Chem; 1998 May; 273(20):12307-15. PubMed ID: 9575183
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Exome sequencing reveals a novel COL2A1 mutation implicated in multiple epiphyseal dysplasia.
    Dasa V; Eastwood JRB; Podgorski M; Park H; Blackstock C; Antoshchenko T; Rogala P; Bieganski T; Jazwinski SM; Czarny-Ratajczak M
    Am J Med Genet A; 2019 Apr; 179(4):534-541. PubMed ID: 30740902
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intrafamilial phenotypic diversity in multiple epiphyseal dysplasia associated with a COL9A2 mutation (EDM2).
    Takahashi M; Matsui Y; Goto T; Nishimura G; Ikegawa S; Ohashi H; Yasui N
    Clin Rheumatol; 2006 Jul; 25(4):591-5. PubMed ID: 16440132
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Syndrome of short stature, microcephaly, mental retardation, and multiple epiphyseal dysplasia--Lowry-Wood syndrome.
    Nevin NC; Thomas PS; Hutchinson J
    Am J Med Genet; 1986 May; 24(1):33-9. PubMed ID: 3706411
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recessive multiple epiphyseal dysplasia - Clinical characteristics caused by rare compound heterozygous SLC26A2 genotypes.
    Kausar M; Mäkitie RE; Toiviainen-Salo S; Ignatius J; Anees M; Mäkitie O
    Eur J Med Genet; 2019 Nov; 62(11):103573. PubMed ID: 30423444
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SLC26A2 (diastrophic dysplasia sulfate transporter) is expressed in developing and mature cartilage but also in other tissues and cell types.
    Haila S; Hästbacka J; Böhling T; Karjalainen-Lindsberg ML; Kere J; Saarialho-Kere U
    J Histochem Cytochem; 2001 Aug; 49(8):973-82. PubMed ID: 11457925
    [TBL] [Abstract][Full Text] [Related]  

  • 47. SLC26A2/DTDST Spectrum: A Cohort of 12 Patients Associated with a Comprehensive Review of the Genotype-Phenotype Correlation.
    Silveira C; da Costa Silveira K; Lacarrubba-Flores MD; Sakata MT; Carbognani SN; Llerena J; Moreno CA; Cavalcanti DP
    Mol Syndromol; 2023 Jan; 13(6):485-495. PubMed ID: 36660027
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dual novel mutations in SLC26A2 in two siblings with multiple epiphyseal dysplasia 4 from a Chinese family: a case report.
    Zhou T; Wang Y; Zhou H; Liao Z; Gao B; Su D; Zheng S; Xu C; Su P
    BMC Med Genet; 2018 May; 19(1):70. PubMed ID: 29724173
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel COL9A3 mutation in a family diagnosed with multiple epiphyseal dysplasia: a case report.
    Jeong C; Lee JY; Kim J; Chae H; Park HI; Kim M; Kim OH; Kim P; Lee YK; Jung J
    BMC Musculoskelet Disord; 2014 Nov; 15():371. PubMed ID: 25381065
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A phenotype intermediate between Desbuquois dysplasia and diastrophic dysplasia secondary to mutations in DTDST.
    Panzer KM; Lachman R; Modaff P; Pauli RM
    Am J Med Genet A; 2008 Nov; 146A(22):2920-4. PubMed ID: 18925670
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multiple epiphyseal dysplasia.
    Dahlqvist J; Orlén H; Matsson H; Dahl N; Lönnerholm T; Gustavson KH
    Acta Orthop; 2009 Dec; 80(6):711-5. PubMed ID: 19995321
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Multiple epiphyseal dysplasia: skeletal dysplasia presenting as neuromuscular disease].
    Jacobse CJ; Verrips A; Terhal PA; Nievelstein R; Rump P
    Ned Tijdschr Geneeskd; 2014; 158(2):A6604. PubMed ID: 24405897
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical and radiographic findings in multiple epiphyseal dysplasia caused by MATN3 mutations: description of 12 patients.
    Mäkitie O; Mortier GR; Czarny-Ratajczak M; Wright MJ; Suri M; Rogala P; Freund M; Jackson GC; Jakkula E; Ala-Kokko L; Briggs MD; Cole WG
    Am J Med Genet A; 2004 Mar; 125A(3):278-84. PubMed ID: 14994237
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel p.A191D matrilin-3 variant in a Vietnamese family with multiple epiphyseal dysplasia: a case report.
    Ho TT; Tran LH; Hoang LT; Doan PKT; Nguyen TT; Nguyen TH; Tran HT; Hoang H; Chu HH; Luong ALT
    BMC Musculoskelet Disord; 2020 Apr; 21(1):216. PubMed ID: 32264862
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical phenotype and molecular diagnosis of multiple epiphyseal dysplasia with relative hip sparing during childhood (EDM2).
    Fiedler J; Stöve J; Heber F; Brenner RE
    Am J Med Genet; 2002 Oct; 112(2):144-53. PubMed ID: 12244547
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comprehensive screening of multiple epiphyseal dysplasia mutations in Japanese population.
    Itoh T; Shirahama S; Nakashima E; Maeda K; Haga N; Kitoh H; Kosaki R; Ohashi H; Nishimura G; Ikegawa S
    Am J Med Genet A; 2006 Jun; 140(12):1280-4. PubMed ID: 16691584
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Does genotype predict development of the spinal deformity in patients with diastrophic dysplasia?
    Remes VM; Hästbacka JR; Poussa MS; Peltonen JI
    Eur Spine J; 2002 Aug; 11(4):327-31. PubMed ID: 12193993
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro proteoglycan sulfation derived from sulfhydryl compounds in sulfate transporter chondrodysplasias.
    Rossi A; Cetta G; Piazza R; Bonaventure J; Steinmann B; Supereti-Furga A
    Pediatr Pathol Mol Med; 2003; 22(4):311-21. PubMed ID: 14692227
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Review: clinical variability and genetic heterogeneity in multiple epiphyseal dysplasia.
    Chapman KL; Briggs MD; Mortier GR
    Pediatr Pathol Mol Med; 2003; 22(1):53-75. PubMed ID: 12687890
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Familial multiple epiphyseal dysplasia due to a matrilin-3 mutation: further delineation of the phenotype including 40 years follow-up.
    Mostert AK; Dijkstra PF; Jansen BR; van Horn JR; de Graaf B; Heutink P; Lindhout D
    Am J Med Genet A; 2003 Aug; 120A(4):490-7. PubMed ID: 12884427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.